"10.1371_journal.pone.0115778","plos one","2014-12-26T00:00:00Z","Henriikka Salomäki; Merja Heinäniemi; Laura H Vähätalo; Liisa Ailanen; Kim Eerola; Suvi T Ruohonen; Ullamari Pesonen; Markku Koulu","Department of Pharmacology, Drug Development and Therapeutics, Institute of Biomedicine, University of Turku, FI-20014 Turku, Finland; Drug Research Doctoral Programme (DRDP), University of Turku, Turku, Finland; School of Medicine, Institute of Biomedicine, University of Eastern Finland, FI-70211 Kuopio, Finland; Turku Center for Disease Modeling (TCDM), University of Turku, FI-20014 Turku, Finland","Conceived and designed the experiments: HS MH LHV LA KE STR UP MK. Performed the experiments: HS MH LHV LA. Analyzed the data: HS MH UP MK. Contributed reagents/materials/analysis tools: MH STR MK. Wrote the paper: HS MH LHV LA KE STR UP MK.","The authors of this manuscript have the following competing interests: Author UP is employed 80% by Orion Corporation/Orion Pharma, Turku, Finland. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","12","Henriikka Salomäki","HS",8,TRUE,8,4,4,8,TRUE,TRUE,FALSE,0,NA,FALSE
